Trial Profile
Off-label ceftaroline fosamil use in patients with various infections
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Jan 2014
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Bacteraemia; Endocarditis; Methicillin-resistant Staphylococcus aureus infections; Osteomyelitis; Pneumonia; Skin and soft tissue infections
- Focus Therapeutic Use
- 11 Jan 2014 New trial record